Filing Details
- Accession Number:
- 0001140361-18-036243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-13 16:37:57
- Reporting Period:
- 2018-08-09
- Accepted Time:
- 2018-08-13 16:37:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613859 | Pra Health Sciences Inc. | PRAH | () | E9 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1541293 | L.p. Xi Fund America North Kkr | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019 | No | No | No | No | |
| 1552453 | Ltd Xi America North Kkr | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019 | No | No | No | No | |
| 1619836 | Kkr Pra Investors Gp Llc | C/O Kohlberg Kravis Roberts &Amp; Co. L.p 9 West 57Th Street, Suite 4200 New York NY 10019 | No | No | No | No | |
| 1619837 | L.p. Xi America North Associates Kkr | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019 | No | No | No | No | |
| 1619838 | L.p. Investors Pra Kkr | C/O Kohlberg Kravis Roberts &Amp; Co. L.p 9 West 57Th Street, Suite 4200 New York NY 10019 | No | No | No | No | |
| 1635867 | Kkr Pra Investors Gp Ii Llc | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-08-09 | 6,500,000 | $101.01 | 6,695,984 | No | 4 | S | Indirect | See Footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnotes |
Footnotes
- This amount represents the secondary public offering price per share of common stock of PRA Health Sciences, Inc., less the underwriting discount of $0.49 per share.
- Securities are held by KKR PRA Investors L.P. KKR PRA Investors GP II LLC is the sole general partner of KKR PRA Investors L.P. KKR PRA Investors GP LLC is the sole member of KKR PRA Investors GP II LLC. KKR North America Fund XI L.P. is the sole member of KKR PRA Investors GP LLC. KKR Associates North America XI L.P. is the general partner of KKR North America Fund XI L.P. KKR North America XI Limited is the general partner of KKR Associates North America XI L.P. KKR Fund Holdings L.P. is the sole shareholder of KKR North America XI Limited. KKR Fund Holdings GP Limited is a general partner of KKR Fund Holdings L.P. KKR Group Holdings Corp. is a general partner of KKR Fund Holdings L.P. and the sole shareholder of KKR Fund Holdings GP Limited. KKR & Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR Management LLC is the controlling shareholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the designated members of KKR Management LLC.
- Each of the Reporting Persons (other than KKR PRA Investors L.P.), disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than KKR PRA Investors L.P.) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
